The “Next Bitcoin”? 10 CENT Crypto Set to Explode

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Ashleigh Palmer Biography and Net Worth

CEO of Provention Bio

Ashleigh Palmer, co-founder and CEO of Provention Bio, is a successful life sciences entrepreneur and innovator with more than 30 years’ experience and expertise in corporate strategy formulation/transactions, preclinical/clinical drug evaluation, and product development/commercialization. Ashleigh has served as CEO for multiple biopharmaceutical companies (both private and public) and has held numerous board director and chairman positions. He is also Founder and President of Creative BioVentures™ Corp. (CBV), a strategic advisory firm serving the biopharmaceutical industry.

What is Ashleigh Palmer's net worth?: The estimated net worth of Ashleigh Palmer is at least $64.20 million as of February 13th, 2023. Mr. Palmer owns 2,570,050 shares of Provention Bio stock worth more than $64,199,849 as of April 26th. This net worth evaluation does not reflect any other investments that Mr. Palmer may own. Learn More about Ashleigh Palmer's net worth.
How do I contact Ashleigh Palmer?: The corporate mailing address for Mr. Palmer and other Provention Bio executives is P.O. BOX 666, OLDWICK NJ, 08858. Provention Bio can also be reached via phone at (908) 428-9136 and via email at [email protected]. Learn More on Ashleigh Palmer's contact information.
Has Ashleigh Palmer been buying or selling shares of Provention Bio?: Ashleigh Palmer has not been actively trading shares of Provention Bio in the last ninety days. Most recently, Ashleigh Palmer sold 25,835 shares of the business's stock in a transaction on Monday, February 13th. The shares were sold at an average price of $10.04, for a transaction totalling $259,383.40. Following the completion of the sale, the chief executive officer now directly owns 2,570,050 shares of the company's stock, valued at $25,803,302. Learn More on Ashleigh Palmer's trading history.
Who are Provention Bio's active insiders?: Provention Bio's insider roster includes Francisco Leon (Insider), Ashleigh Palmer (CEO), and Eleanor Ramos (Insider). Learn More on Provention Bio's active insiders.

Ashleigh Palmer Insider Trading History at Provention Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/13/2023	Sell	25,835	$10.04	$259,383.40	2,570,050
2/10/2023	Sell	50,000	$10.11	$505,500.00	2,570,050
1/18/2023	Sell	24,165	$10.27	$248,174.55	2,570,050
11/30/2021	Buy	3,750	$6.66	$24,975.00
8/17/2020	Buy	2,800	$12.83	$35,924.00	2,565,800
12/20/2019	Buy	2,075	$11.39	$23,634.25	2,563,000
9/24/2019	Buy	3,000	$8.38	$25,140.00
8/8/2019	Buy	10,600	$9.15	$96,990.00
6/18/2019	Buy	4,000	$10.83	$43,320.00
12/31/2018	Buy	5,825	$1.71	$9,960.75

Ashleigh Palmer Buying and Selling Activity at Provention Bio

Provention Bio Company Overview

Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn's disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ.

Today's Range

Now: $24.98

$24.98

$25.00

50 Day Range

MA: $24.58

$23.74

$24.98

2 Week Range

Now: $24.98

$3.18

$25.00

Volume

9,124,100 shs

Average Volume

2,277,701 shs

Market Capitalization

$2.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.47